Literature DB >> 22966301

A combination of green tea extract, specific nutrient mixture and quercetin: An effective intervention treatment for the regression of N-methyl-N-nitrosourea (MNU)-induced mammary tumors in Wistar rats.

Anup Kale1, Sonia Gawande, Swati Kotwal, Shrirang Netke, M Waheed Roomi, Vadim Ivanov, Aleksandra Niedzwiecki, Matthias Rath.   

Abstract

Mammary tumors were developed by intraperitoneal injection of N-methyl-N-nitrosourea (MNU) in 21-day-old, sexually immature female Wistar rats. Injection of MNU was repeated 14 weeks after the first one. When palpable tumors were evident in all of the rats, various dietary treatments were initiated for a period of 8 weeks. The treatments were designed to provide 30 mg green tea extract either alone or as a nutrient mixture (E). E was then expanded to include either a nutrient supplement (N), quercetin (Q) or both (N+Q). At the end of the treatment, tumor size/rat measured in the live rats was significantly lower in the groups receiving E, E+Q, E+N and E+N+Q than in the positive control (PC) group which did not receive any dietary treatment. Tumor number/rat, tumor volume/rat and tumor weight/rat were evaluated after sacrificing the rats on the 60th day. The rats receiving E+N+Q showed significantly lower values for the three parameters as compared to the PC group. The PC group showed 24 carcinomas mostly of grade III severity, while the E+N+Q group had only 6 carcinomas, all of which were of grade II severity.

Entities:  

Year:  2010        PMID: 22966301      PMCID: PMC3436414          DOI: 10.3892/ol_00000056

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

Review 1.  Comparative study of human and rat mammary tumorigenesis.

Authors:  J Russo; B A Gusterson; A E Rogers; I H Russo; S R Wellings; M J van Zwieten
Journal:  Lab Invest       Date:  1990-03       Impact factor: 5.662

2.  Effects of dietary folate on the development and progression of mammary tumors in rats.

Authors:  Joanne Kotsopoulos; Alan Medline; Richard Renlund; Kyoung-Jin Sohn; Rochelle Martin; Stephen W Hwang; Suying Lu; Michael C Archer; Young-In Kim
Journal:  Carcinogenesis       Date:  2005-05-11       Impact factor: 4.944

3.  4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.

Authors:  A Green; A Shilkaitis; K Christov
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

4.  Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells.

Authors:  N Ahmad; D K Feyes; A L Nieminen; R Agarwal; H Mukhtar
Journal:  J Natl Cancer Inst       Date:  1997-12-17       Impact factor: 13.506

5.  Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea.

Authors:  H J Thompson; M Singh; J McGinley
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

6.  Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid.

Authors:  K Melancon; Q Cheng; T L Kiefer; J Dai; L Lai; C Dong; L Yuan; A Collins; A Thiyagarajah; S Long; S M Hill
Journal:  Cancer Lett       Date:  2005-09-08       Impact factor: 8.679

7.  Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar: han rats to mammary carcinogenesis induction.

Authors:  B Bojková; I Ahlers; P Kubatka; K Mociková; M Mníchová; E Ahlersová
Journal:  Neoplasma       Date:  2000       Impact factor: 2.575

8.  Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats.

Authors:  Joanne Kotsopoulos; Kyoung-Jin Sohn; Rochelle Martin; Monica Choi; Richard Renlund; Colin McKerlie; Stephen W Hwang; Alan Medline; Young-In J Kim
Journal:  Carcinogenesis       Date:  2003-05       Impact factor: 4.944

9.  Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea.

Authors:  H J Thompson; J N McGinley; K Rothhammer; M Singh
Journal:  Carcinogenesis       Date:  1995-10       Impact factor: 4.944

10.  Lifetime dose-response relationships for mammary tumor induction by a single administration of N-methyl-N-nitrosourea.

Authors:  D L McCormick; C B Adamowski; A Fiks; R C Moon
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

View more
  7 in total

Review 1.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

Review 2.  Micronutrient synergy--a new tool in effective control of metastasis and other key mechanisms of cancer.

Authors:  A Niedzwiecki; M W Roomi; T Kalinovsky; M Rath
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

3.  Methodological problems with population cancer studies: The forgotten confounding factors.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2015-05-29

4.  Progress of Tumor Growth and Metastasis After Inoculation of B16FO Melanoma Cells in Kidney of Female Nude Mice Is Inhibited by a Novel Nutrient Mixture.

Authors:  M Waheed Roomi; Bilwa Bhanap; Aleksandra Niedzwiecki; Matthias Rath
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

5.  Chebulagic acid from Terminalia chebula causes G1 arrest, inhibits NFκB and induces apoptosis in retinoblastoma cells.

Authors:  Naresh Kumar; D Gangappa; Geetika Gupta; Roy Karnati
Journal:  BMC Complement Altern Med       Date:  2014-08-29       Impact factor: 3.659

Review 6.  Anticancer Efficacy of Polyphenols and Their Combinations.

Authors:  Aleksandra Niedzwiecki; Mohd Waheed Roomi; Tatiana Kalinovsky; Matthias Rath
Journal:  Nutrients       Date:  2016-09-09       Impact factor: 5.717

Review 7.  Polyphenols as Promising Drugs against Main Breast Cancer Signatures.

Authors:  María Losada-Echeberría; María Herranz-López; Vicente Micol; Enrique Barrajón-Catalán
Journal:  Antioxidants (Basel)       Date:  2017-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.